Strategic Alliance Magazine Q2 2016 - 15
COLL ABORATIVE BUZZ
intelligence experience and the Fin Tech innovation
of our PurpleTRAC sanctions compliance and risk
management product," said Pole Star managing
director Julian Longson. PurpleTRAC solution scans
ships and their associates against a comprehensive
set of trade compliance lists that include over 400
economic sanctions, denied parties, and embargoes
lists. "Traffic light" icons highlight the severity.
Thomson Reuters Elite, an ASAP
corporate member, and PaayaTech, Inc.
technical support and consulting services formed an
alliance to help law firms and professional services
organizations run operations such as risk, client,
and financial management. PaayaTech's custom-designed application is geared to enhance customer
experience, increase productivity, and foster collaboration among users though technical support,
such as customization, configuration of WebView,
and installation for a variety of market sectors,
such as mobile, in-house portal applications, and
e-commerce. Their consulting services address IT
solutions and create customized reports.
renal transplant patients in a two-year random trial
examining surrogate markers while comparing
immunosuppressive agents. Astellas designed the
clinical trial while Transplant Genomics will measure molecular signatures of immune activation in
renal transplant patients using its TruGraf test.
Ipsen, an ASAP corporate member,
and Exelixis, Inc., have signed an
exclusive agreement
for further development and commercialization of
Exelixis's oncology drug cabozantinib, focusing on
advanced renal cell carcinoma. Also included in the
agreement are the rights to Exelixis's Cometriq drug
for locally advanced or metastatic medullary thyroid
cancer. "Ipsen's established international oncology
marketing presence, late-stage clinical development
expertise, and shared vision with Exelixis for the
franchise potential of cabozantinib will accelerate
cabozantinib's commercialization in its territories,
while Exelixis remains focused on our launch in the
United States," said Michael M. Morrissey, president
and CEO of Exelixis. "While our immediate priority
will be on advanced renal cell carcinoma, Exelixis
and Ipsen are committed to exploring and potentially
developing cabozantinib in a variety of cancer settings."
A laboratory services agreement
went into effect between Astellas
Pharmaceuticals, an ASAP global
member, and Transplant Genomics,
a molecular diagnostics company committed to
improving organ transplants. Transplant Genomics will provide funding and blood samples from
15
SUMMER * 2016 | STRATEGIC ALLIANCE MAGAZINE
Table of Contents for the Digital Edition of Strategic Alliance Magazine Q2 2016
No label
Strategic Alliance Magazine Q2 2016 - No label
Strategic Alliance Magazine Q2 2016 - 2
Strategic Alliance Magazine Q2 2016 - 3
Strategic Alliance Magazine Q2 2016 - 4
Strategic Alliance Magazine Q2 2016 - 5
Strategic Alliance Magazine Q2 2016 - 6
Strategic Alliance Magazine Q2 2016 - 7
Strategic Alliance Magazine Q2 2016 - 8
Strategic Alliance Magazine Q2 2016 - 9
Strategic Alliance Magazine Q2 2016 - 10
Strategic Alliance Magazine Q2 2016 - 11
Strategic Alliance Magazine Q2 2016 - 12
Strategic Alliance Magazine Q2 2016 - 13
Strategic Alliance Magazine Q2 2016 - 14
Strategic Alliance Magazine Q2 2016 - 15
Strategic Alliance Magazine Q2 2016 - 16
Strategic Alliance Magazine Q2 2016 - 17
Strategic Alliance Magazine Q2 2016 - 18
Strategic Alliance Magazine Q2 2016 - 19
Strategic Alliance Magazine Q2 2016 - 20
Strategic Alliance Magazine Q2 2016 - 21
Strategic Alliance Magazine Q2 2016 - 22
Strategic Alliance Magazine Q2 2016 - 23
Strategic Alliance Magazine Q2 2016 - 24
Strategic Alliance Magazine Q2 2016 - 25
Strategic Alliance Magazine Q2 2016 - 26
Strategic Alliance Magazine Q2 2016 - 27
Strategic Alliance Magazine Q2 2016 - 28
Strategic Alliance Magazine Q2 2016 - 29
Strategic Alliance Magazine Q2 2016 - 30
Strategic Alliance Magazine Q2 2016 - 31
Strategic Alliance Magazine Q2 2016 - 32
Strategic Alliance Magazine Q2 2016 - 33
Strategic Alliance Magazine Q2 2016 - 34
Strategic Alliance Magazine Q2 2016 - 35
Strategic Alliance Magazine Q2 2016 - 36
Strategic Alliance Magazine Q2 2016 - 37
Strategic Alliance Magazine Q2 2016 - 38
Strategic Alliance Magazine Q2 2016 - 39
Strategic Alliance Magazine Q2 2016 - 40
Strategic Alliance Magazine Q2 2016 - 41
Strategic Alliance Magazine Q2 2016 - 42
Strategic Alliance Magazine Q2 2016 - 43
Strategic Alliance Magazine Q2 2016 - 44
Strategic Alliance Magazine Q2 2016 - 45
Strategic Alliance Magazine Q2 2016 - 46
Strategic Alliance Magazine Q2 2016 - 47
Strategic Alliance Magazine Q2 2016 - 48
Strategic Alliance Magazine Q2 2016 - 49
Strategic Alliance Magazine Q2 2016 - 50
Strategic Alliance Magazine Q2 2016 - 51
Strategic Alliance Magazine Q2 2016 - 52
Strategic Alliance Magazine Q2 2016 - 53
Strategic Alliance Magazine Q2 2016 - 54
Strategic Alliance Magazine Q2 2016 - 55
Strategic Alliance Magazine Q2 2016 - 56
Strategic Alliance Magazine Q2 2016 - 57
Strategic Alliance Magazine Q2 2016 - 58
Strategic Alliance Magazine Q2 2016 - 59
Strategic Alliance Magazine Q2 2016 - 60
https://www.nxtbook.com/allen/stam/23-2
https://www.nxtbook.com/allen/stam/23-1
https://www.nxtbook.com/allen/stam/22-4
https://www.nxtbook.com/allen/stam/22-3
https://www.nxtbook.com/allen/stam/22-2
https://www.nxtbook.com/allen/stam/22-1
https://www.nxtbook.com/allen/stam/21-4
http://www.brightcopy.net/allen/stam/21-3
http://www.brightcopy.net/allen/stam/21-2
http://www.brightcopy.net/allen/stam/21-1
http://www.brightcopy.net/allen/stam/20-4
http://www.brightcopy.net/allen/stam/20-3
http://www.brightcopy.net/allen/stam/20-2
http://www.brightcopy.net/allen/stam/20-1
http://www.brightcopy.net/allen/stam/19-4
http://www.brightcopy.net/allen/stam/19-3
http://www.brightcopy.net/allen/stam/19-2
http://www.brightcopy.net/allen/stam/19-1
http://www.brightcopy.net/allen/stam/18-4
http://www.brightcopy.net/allen/stam/18-3
http://www.brightcopy.net/allen/stam/18-2
http://www.brightcopy.net/allen/stam/18-1
http://www.brightcopy.net/allen/stam/17-4
http://www.brightcopy.net/allen/stam/17-3
http://www.brightcopy.net/allen/stam/17-2
http://www.brightcopy.net/allen/stam/17-1
http://www.brightcopy.net/allen/stam/16-3
http://www.brightcopy.net/allen/stam/16-2
http://www.brightcopy.net/allen/stam/16-1
http://www.brightcopy.net/allen/stam/15-4
http://www.brightcopy.net/allen/stam/15-03
http://www.brightcopy.net/allen/stam/15-02
https://www.nxtbook.com/allen/stam/15-1
https://www.nxtbook.com/allen/stam/14-4
https://www.nxtbook.com/allen/stam/14-3
https://www.nxtbook.com/allen/stam/14-2
https://www.nxtbookmedia.com